Mia Seilern
PABA
⚠️ Data is provided for informational purposes only. It may contain inaccuracies and should be independently verified. This is not medical advice. Consult a healthcare professional before making health decisions.

Description: PABA — chemical UV filter (UVB); largely phased out due to allergy and sensitization concerns.

All Functions: chemical UV filter (UVB); largely phased out due to allergy and sensitization concerns

Quick Facts:

  • Category: sunscreen
  • Regulatory Note: Prohibited in the EU

Proven Benefits At A Glance:

  • PABA is a chemical sunscreen ingredient that was popular after World War II but has been largely phased out
  • It was found to be a common skin sensitizer and could trigger cross-reactions with similar chemicals
  • Prolonged PABA exposure has been linked to autoimmune responses including systemic lupus erythematosus and dermatomyositis
  • In animal studies, PABA showed promise in slowing UV-induced tumor development
  • A synthetic PABA derivative (ethylhexyl dimethyl PABA) used in modern sunscreens has raised toxicity concerns in research
Safety: AvoidResearch confidence: Good

Safety tier is a starting heuristic from regulatory status and comedogenic rating, not a dermatological verdict — see our Terms for the full disclaimer. Research confidence reflects how many real cited studies back this ingredient, not the strength of their findings.

🧪 PABA

Chemical structure of PABA

PABA

CAS Number: 150-13-0

Also Known As:

Category: sunscreen

EC Number: 205-753-0

Korean Name: 파바에스에이치-펜타펩타이드-9

4-Aminobenzoic acid

PABA is a sunscreen ingredient used in skincare formulations.

chemical UV filter (UVB); largely phased out due to allergy and sensitization concerns

🌍 Regulatory Status

EU: ProhibitedUS: No restriction on file

📊 Comedogenicity

No data yet
Not rated for this ingredient yet.

📚 Research & Evidence

PUBMED CITATIONS
5
Data sources: EU CosIng PubMed

🔬 The Science

PABA, or para-aminobenzoic acid, has a complicated history in skincare. Originally embraced as a sunscreen hero in the post-World War II era, dermatologists gradually recognized serious problems. According to *Australasian Journal of Dermatology* (1999), PABA turned out to be a fairly common skin sensitizer—meaning it frequently triggered allergic contact reactions. More concerning, it could cross-sensitize with chemically similar compounds both through skin contact and when taken as systemic medications. Extended PABA exposure raised another red flag: #1: it was associated with autoimmune responses, particularly systemic lupus erythematosus and dermatomyositis. These complications were serious enough that dermatological societies in Australia discussed them formally in 1964 and 1965, ultimately contributing to PABA’s gradual withdrawal from sunscreen products.

On the beneficial side, animal research suggested real photoprotective potential. A study in *Archives of Dermatological Research* (1990) tested a 5% PABA solution on hairless mice exposed to UVB radiation. #2: PABA significantly delayed tumor development time and reduced both overall tumor yield and carcinoma yield (with statistical significance, p < 0.05). Interestingly, #3: skin thickness in PABA-protected mice matched untreated controls, whereas unprotected UV-exposed skin became significantly thicker, suggesting PABA prevented some UV damage at a tissue level. Today's concern centers on ethylhexyl dimethyl PABA, an oil-soluble derivative commonly used in modern sunscreens (typically at 0.5–2.0% concentration). According to *Toxicology Research* (2019), animal studies have identified toxicity to the testis, epididymis, spleen, and liver.

Laboratory tests on human skin cells showed #4: ethylhexyl dimethyl PABA inhibited cell growth and DNA synthesis at low doses and halted the cell cycle in melanoma cells. Most significantly, #5: this compound showed increased mutagenicity (ability to cause genetic mutations) when exposed to sunlight, raising concern that it could paradoxically increase sun-induced cancer risk despite blocking UVB. The same source notes clinical human data remain limited. Risk assessment calculations suggested a safety margin of 180 for maximum-use scenarios, though the presence of mutagenic potential under sun exposure remains a concern requiring further investigation.

💧 Skin Type Compatibility

No data yet
Per-skin-type data isn’t curated for this ingredient yet.

⚠️ Don’t Combine With

No data yet
No known incompatibilities on file for this ingredient.

🧴 Products Containing PABA

📄 Related Research

Matched by search — not necessarily verified support for every statement above.

Similar Ingredients

3-BENZYLIDENE CAMPHOR
3-BENZYLIDENE CAMPHOR
sunscreen
View
4-METHYLBENZYLIDENE CAMPHOR
4-METHYLBENZYLIDENE CAMPHOR
sunscreen
View
7-DEHYDROCHOLESTERYL PALMITATE
7-DEHYDROCHOLESTERYL PALMITATE
sunscreen
View
Avobenzone
Avobenzone
sunscreen
View
BUTYL METHOXYDIBENZOYLMETHANE
BUTYL METHOXYDIBENZOYLMETHANE
sunscreen
View
DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE
DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE
sunscreen
View
DROMETRIZOLE TRISILOXANE
DROMETRIZOLE TRISILOXANE
sunscreen
View
ETHYLHEXYL SALICYLATE
ETHYLHEXYL SALICYLATE
sunscreen
View